| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 59 |
| 1 | ALENDRONATE SODIUM | 33 |
| 2 | ADALIMUMAB | 31 |
| 3 | COPPER | 27 |
| 4 | ERGOCALCIFEROL | 20 |
| 5 | METHOTREXATE SODIUM | 20 |
| 6 | LEVOTHYROXINE SODIUM | 16 |
| 7 | ACETAMINOPHEN | 14 |
| 8 | METHOTREXATE | 14 |
| 9 | PREDNISONE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | 1 | 0.0055 |
| 1 | TERBINAFINE TABLETS 250 MG | 4 | 0.0031 |
| 2 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 3 | MIFEPRISTONE | 10 | 0.0021 |
| 4 | DROSPIRENONE AND ESTRADIOL | 1 | 0.0019 |
| 5 | TAMOXIFEN CITRATE | 9 | 0.0016 |
| 6 | MINERAL OIL, PETROLATUM | 1 | 0.0015 |
| 7 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 8 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0011 |
| 9 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 3 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 73 |
| 1 | Progestin-containing Intrauterine System [EPC] | 61 |
| 2 | Corticosteroid [EPC] | 29 |
| 3 | Copper-containing Intrauterine Device [EPC] | 27 |
| 4 | Estrogen [EPC] | 26 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 22 |
| 7 | Provitamin D2 Compound [EPC] | 20 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 9 | Vitamin C [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progestin Antagonist [EPC] | 10 | 0.0021 |
| 1 | Ergot Derivative [EPC] | 4 | 0.0008 |
| 2 | Estrogen Agonist/Antagonist [EPC] | 2 | 0.0008 |
| 3 | Provitamin D2 Compound [EPC] | 20 | 0.0007 |
| 4 | Copper-containing Intrauterine Device [EPC] | 27 | 0.0005 |
| 5 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 6 | Calcitonin [EPC] | 1 | 0.0003 |
| 7 | Progestin [EPC] | 73 | 0.0003 |
| 8 | Antiseptic [EPC] | 1 | 0.0002 |
| 9 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |